Ahead of the midterm elections, the president said that all states had opted in to an effort to align Medicaid’s prices for medicines with those in other wealthy countries.
Trump Promotes Program to Reduce Medicaid Drug Prices
The New York Times – Business:
This post first appeared in The New York Times – Business. Read the original article.
Written by
in
Disabilities, Drugs (Pharmaceuticals), Federal-State Relations (US), Health Insurance and Managed Care, Medicaid, Obesity, Prices (Fares, Fees and Rates), Regulation and Deregulation of Industry, Republican Party, States (US), Trump, Donald J, TrumpRX (Web Site), United States Politics and Government